# Hartford Insurance Group, Inc.: financial statements, quarterly

HIG · NYSE · CIK 874766 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/hig.md) · [Financials](/companies/hig/financials.md) · [Filings](/companies/hig/filings.md) · [Insiders](/companies/hig/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/hig/financials.md?period=annual).

## Income statement

| Line item | Unit | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [6,400](/filings/0000874766-24-000016.md) | [352](/filings/0000874766-25-000052.md) | [364](/filings/0000874766-25-000084.md) | [369](/filings/0000874766-25-000107.md) | [373 d](/filings/0000874766-26-000012.md) | [366](/filings/0000874766-26-000037.md) | [110](/filings/0000874766-26-000060.md) | [109](/filings/0000874766-26-000078.md) | [1,181 d](/filings/0000874766-26-000012.md) | [392](/filings/0000874766-26-000037.md) | [111](/filings/0000874766-26-000060.md) | [111](/filings/0000874766-26-000078.md) |
| Selling, general and administrative | $m | [1,214 d](/filings/0000874766-26-000012.md) | [1,283](/filings/0000874766-25-000052.md) | [1,285](/filings/0000874766-25-000084.md) | [1,323](/filings/0000874766-25-000107.md) | [1,367 d](/filings/0000874766-26-000012.md) | [1,352](/filings/0000874766-26-000037.md) | [1,138](/filings/0000874766-26-000060.md) | [1,203](/filings/0000874766-26-000078.md) | [2,096 d](/filings/0000874766-26-000012.md) | [1,447](/filings/0000874766-26-000037.md) | [1,215](/filings/0000874766-26-000060.md) | [1,177](/filings/0000874766-26-000078.md) |
| Operating income | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Interest expense | $m | [49.0 d](/filings/0000874766-26-000012.md) | [50.0](/filings/0000874766-25-000052.md) | [50.0](/filings/0000874766-25-000084.md) | [49.0](/filings/0000874766-25-000107.md) | [50.0 d](/filings/0000874766-26-000012.md) | [50.0](/filings/0000874766-26-000037.md) | [50.0](/filings/0000874766-26-000060.md) | [50.0](/filings/0000874766-26-000078.md) | [49.0 d](/filings/0000874766-26-000012.md) | [50.0](/filings/0000874766-26-000037.md) | [50.0](/filings/0000874766-26-000060.md) | [50.0](/filings/0000874766-26-000078.md) |
| Income tax | $m | [179 d](/filings/0000874766-26-000012.md) | [158](/filings/0000874766-25-000052.md) | [174](/filings/0000874766-25-000084.md) | [185](/filings/0000874766-25-000107.md) | [221 d](/filings/0000874766-26-000012.md) | [153](/filings/0000874766-26-000037.md) | [236](/filings/0000874766-26-000060.md) | [222](/filings/0000874766-26-000078.md) | [326 d](/filings/0000874766-26-000012.md) | [201](/filings/0000874766-26-000037.md) | [251](/filings/0000874766-26-000060.md) | [321](/filings/0000874766-26-000078.md) |
| Net income | $m | [771](/filings/0000874766-24-000016.md) | [753](/filings/0000874766-25-000052.md) | [738](/filings/0000874766-25-000084.md) | [767](/filings/0000874766-25-000107.md) | [853 d](/filings/0000874766-26-000012.md) | [630](/filings/0000874766-26-000037.md) | [995](/filings/0000874766-26-000060.md) | [1,080](/filings/0000874766-26-000078.md) | [1,131 d](/filings/0000874766-26-000012.md) | [856](/filings/0000874766-26-000037.md) | [1,298](/filings/0000874766-26-000060.md) | [1,323](/filings/0000874766-26-000078.md) |
| Diluted EPS | $ per share | [2.51](/filings/0000874766-24-000016.md) | [2.47](/filings/0000874766-25-000052.md) | [2.44](/filings/0000874766-25-000084.md) | [2.56](/filings/0000874766-25-000107.md) | not reported | [2.15](/filings/0000874766-26-000037.md) | [3.44](/filings/0000874766-26-000060.md) | [3.77](/filings/0000874766-26-000078.md) | not reported | [3.04](/filings/0000874766-26-000037.md) | [4.68](/filings/0000874766-26-000060.md) | [4.82](/filings/0000874766-26-000078.md) |
| Basic EPS | $ per share | [2.55](/filings/0000874766-24-000016.md) | [2.51](/filings/0000874766-25-000052.md) | [2.48](/filings/0000874766-25-000084.md) | [2.60](/filings/0000874766-25-000107.md) | not reported | [2.18](/filings/0000874766-26-000037.md) | [3.49](/filings/0000874766-26-000060.md) | [3.82](/filings/0000874766-26-000078.md) | not reported | [3.08](/filings/0000874766-26-000037.md) | [4.73](/filings/0000874766-26-000060.md) | [4.88](/filings/0000874766-26-000078.md) |

- Revenue: us-gaap:Revenues, us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: not reported
- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $bn | [0.1](/filings/0000874766-25-000023.md) | [0.3](/filings/0000874766-24-000073.md) | [0.2](/filings/0000874766-24-000108.md) | [0.2](/filings/0000874766-24-000122.md) | [0.2](/filings/0000874766-26-000012.md) | [0.1](/filings/0000874766-25-000052.md) | [0.2](/filings/0000874766-25-000084.md) | [0.2](/filings/0000874766-25-000107.md) | [0.1](/filings/0000874766-26-000078.md) | [0.2](/filings/0000874766-26-000037.md) | [0.1](/filings/0000874766-26-000060.md) | [0.1](/filings/0000874766-26-000078.md) |
| Total assets | $bn | [76.8](/filings/0000874766-25-000023.md) | [77.7](/filings/0000874766-24-000073.md) | [79.0](/filings/0000874766-24-000108.md) | [81.2](/filings/0000874766-24-000122.md) | [80.9](/filings/0000874766-26-000012.md) | [82.3](/filings/0000874766-25-000052.md) | [83.6](/filings/0000874766-25-000084.md) | [85.0](/filings/0000874766-25-000107.md) | [86.0](/filings/0000874766-26-000078.md) | [86.3](/filings/0000874766-26-000037.md) | [88.0](/filings/0000874766-26-000060.md) | [87.1](/filings/0000874766-26-000078.md) |
| Total liabilities | $bn | [61.5](/filings/0000874766-25-000023.md) | [62.2](/filings/0000874766-24-000073.md) | [63.4](/filings/0000874766-24-000108.md) | [64.2](/filings/0000874766-24-000122.md) | [64.5](/filings/0000874766-26-000012.md) | [65.5](/filings/0000874766-25-000052.md) | [66.1](/filings/0000874766-25-000084.md) | [66.5](/filings/0000874766-25-000107.md) | [67.1](/filings/0000874766-26-000078.md) | [67.4](/filings/0000874766-26-000037.md) | [68.4](/filings/0000874766-26-000060.md) | [68.3](/filings/0000874766-26-000078.md) |
| Long-term debt | $bn | [4.4](/filings/0000874766-25-000023.md) | [4.4](/filings/0000874766-24-000073.md) | [4.4](/filings/0000874766-24-000108.md) | [4.4](/filings/0000874766-24-000122.md) | [4.4](/filings/0000874766-26-000012.md) | [4.4](/filings/0000874766-25-000052.md) | [4.4](/filings/0000874766-25-000084.md) | [4.4](/filings/0000874766-25-000107.md) | [4.4](/filings/0000874766-26-000012.md) | [4.4](/filings/0000874766-26-000037.md) | [4.4](/filings/0000874766-26-000060.md) | [4.4](/filings/0000874766-26-000078.md) |
| Current portion of debt | $bn | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Short-term borrowings | $bn | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $bn | [15.3](/filings/0000874766-26-000012.md) | [15.5](/filings/0000874766-25-000052.md) | [15.7](/filings/0000874766-25-000084.md) | [17.0](/filings/0000874766-25-000107.md) | [16.4](/filings/0000874766-26-000012.md) | [16.8](/filings/0000874766-26-000037.md) | [17.5](/filings/0000874766-26-000060.md) | [18.5](/filings/0000874766-26-000078.md) | [19.0](/filings/0000874766-26-000078.md) | [18.9](/filings/0000874766-26-000037.md) | [19.6](/filings/0000874766-26-000060.md) | [18.9](/filings/0000874766-26-000078.md) |

- Cash and equivalents: us-gaap:Cash
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent, us-gaap:LongTermDebt
- Current portion of debt: not reported
- Short-term borrowings: not reported
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [1,627 d](/filings/0000874766-26-000012.md) | [1,097](/filings/0000874766-25-000052.md) | [1,260 d](/filings/0000874766-25-000084.md) | [1,678 d](/filings/0000874766-25-000107.md) | [1,874 d](/filings/0000874766-26-000012.md) | [985](/filings/0000874766-26-000037.md) | [1,291 d](/filings/0000874766-26-000060.md) | [1,838 d](/filings/0000874766-26-000078.md) | [1,808 d](/filings/0000874766-26-000012.md) | [1,045](/filings/0000874766-26-000037.md) | [1,189 d](/filings/0000874766-26-000060.md) | [2,951 d](/filings/0000874766-26-000078.md) |
| Capital expenditure | $m | [64.0 d](/filings/0000874766-26-000012.md) | [50.0](/filings/0000874766-25-000052.md) | [61.0 d](/filings/0000874766-25-000084.md) | [60.0 d](/filings/0000874766-25-000107.md) | [(26.0) d](/filings/0000874766-26-000012.md) | [38.0](/filings/0000874766-26-000037.md) | [40.0 d](/filings/0000874766-26-000060.md) | [45.0 d](/filings/0000874766-26-000078.md) | [46.0 d](/filings/0000874766-26-000012.md) | [31.0](/filings/0000874766-26-000037.md) | [(115) d](/filings/0000874766-26-000060.md) | not reported |
| Dividends paid | $m | [129 d](/filings/0000874766-26-000012.md) | [141](/filings/0000874766-25-000052.md) | [140 d](/filings/0000874766-25-000084.md) | [138 d](/filings/0000874766-25-000107.md) | [137 d](/filings/0000874766-26-000012.md) | [150](/filings/0000874766-26-000037.md) | [149 d](/filings/0000874766-26-000060.md) | [147 d](/filings/0000874766-26-000078.md) | [146 d](/filings/0000874766-26-000012.md) | [167](/filings/0000874766-26-000037.md) | [165 d](/filings/0000874766-26-000060.md) | [164 d](/filings/0000874766-26-000078.md) |
| Share repurchases | $m | [350 d](/filings/0000874766-26-000012.md) | [350](/filings/0000874766-25-000052.md) | [350 d](/filings/0000874766-25-000084.md) | [400 d](/filings/0000874766-25-000107.md) | [414 d](/filings/0000874766-26-000012.md) | [400](/filings/0000874766-26-000037.md) | [415 d](/filings/0000874766-26-000060.md) | [400 d](/filings/0000874766-26-000078.md) | [400 d](/filings/0000874766-26-000012.md) | [450](/filings/0000874766-26-000037.md) | [466 d](/filings/0000874766-26-000060.md) | [475 d](/filings/0000874766-26-000078.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [319](/filings/0000874766-24-000073.md) | [313](/filings/0000874766-24-000108.md) | [309](/filings/0000874766-24-000122.md) | [303](/filings/0000874766-25-000052.md) | [300](/filings/0000874766-25-000084.md) | [298](/filings/0000874766-25-000107.md) | [291](/filings/0000874766-26-000037.md) | [288](/filings/0000874766-26-000060.md) | [285](/filings/0000874766-26-000078.md) | [280](/filings/0000874766-26-000037.md) | [276](/filings/0000874766-26-000060.md) | [273](/filings/0000874766-26-000078.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 267,413,397 at 2026-10-23, from the cover of the [10-Q filed 2026-10-26](/filings/0000874766-26-000078.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 26, 2026, 16:19 ET. No prices; not investment advice.